Metabolism At Creative Enzymes Articles & Analysis: Older
8 news found
Creative Enzymes, a trailblazing leader in the field of enzyme research and manufacturing, is excited to announce its latest innovation: Diamine Oxidase (Food Grade). ...
Optibrium and Lhasa Limited publish joint peer-reviewed research in the Journal of Medicinal Chemistry, expanding predictive modelling beyond human Cytochrome P450. Study demonstrates novel predictive models for drug metabolism to improve drug design and Optibrium and Lhasa Limited, two of the leading developers of software and artificial intelligence (AI) solutions for drug discovery and ...
Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its metabolite identification services of biopharmaceuticals for an accurate and efficient analysis of the metabolism for your biological drugs in vivo. ...
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering at researches and trials in order to provide customers with various enzyme services and products as many as possible. ...
Recently, the product manager of Creative Enzymes announced the technological upgrade of the Metabolic Flux Analysis service to quantify fluxes in both prokaryotic and eukaryotic systems. ...
HemoShear Therapeutics, Inc., a clinical stage company developing treatments for rare metabolic disorders, today announced the publication of in vitro pharmacology data in the journal Molecular Genetics and Metabolism, demonstrating that the oral small molecule HST5040 may be effective in treating Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA). The company has initiated the HERO (HElp ...
Researchers identify a novel approach to enhance tissue growth Because most human tissues do not regenerate spontaneously, advances in tissue repair and organ regeneration could benefit many patients with a wide variety of medical conditions. Now a research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and Dana-Farber/Boston Children’s Cancer and Blood ...
Salem, NY -- Three recent studies show that a genetic variant makes sufferers of multiple chemical sensitivity (MCS) more likely to develop the condition. In 2004, McKeown-Eyssen studied 203 MCS sufferers and 162 controls and found that genetic differences relating to detoxification processes were present more often in those with MCS than those without. The study concluded that 'a genetic ...